chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Hospitalized 1/7/22; COVID-19 positive 1.7.,22; fully vaccinated. Only hospitalized for 6 hours. HISTORY OF PRESENT ILLNESS: Patient is a 67-year-old female with past medical history of type 2 diabetes, HLD, HTN, Iron deficiency anemia, Anxiety, depression, Anemia due to stage IV CKD, CKD stage IV, LLE DVT 6/21 s/p mechanical thrombectomy currently on coumadin, Pulmonary embolism 5/21, and right breast cancer s/p right partial mastectomy in 2018 presenting with hypoglycemia (28, 40, 46) for the past 3 mornings. On 12/30 it was 28. Patient takes glimepiride at home but stopped taking her nighttime dose around 12/25 and stopped taking her morning dose as well today. She was prescribed Levemir as well but has not taken this for months because she has been having difficulty regulating her blood glucose. She has been self treating her low blood sugar with candy and Pepsi.  She also has been having generalized fatigue and cough with sputum production for the past 2.5 weeks. She is unsure of what color her sputum is. Patient states husband is also displaying similar symptoms. Left Flank pain is dull, achy that has been there for years. The pain does not radiate and is constant in nature. She had a colonoscopy around 5 years ago and patient states that they removed polyps. Denies fever, chills, SOB, Chest pain, Leg pain, headache, dizziness, congestion, rhinorrhea. In the ED, patient found to be COVID-19 positive. Chest x-ray showed no acute cardiopulmonary abnormalities. Glucose 133, K 3.6. ASSESSMENT/PLAN: Patient is a 67-year-old female with past medical history of type 2 diabetes, HLD, HTN, Iron deficiency anemia, Anxiety, depression, CKD stage IV, LLE DVT 6/21 s/p mechanical thrombectomy currently on Coumadin, Pulmonary embolism 5/21, and right breast cancer s/p right partial mastectomy in 2018 admitted due to recurrent hypoglycemia in the setting of COVID-19.  DETAILS OF HOSPITAL STAY: HOSPITAL COURSE: DISCHARGE DIAGNOSES: COVID-19, Hypoglycemia. After completion of history and physical patient decided that she would like to leave against medical advice. Please see H&P note for further details. BP (!) 181/61| Pulse 70 | Temp 36.3 °C (Axillary) | Resp. 25 | HT 1.6 m | WT 101 kg | SpO2 98% | BMI 39.45 kg/m² . Patient became hysterical when resident tried to discuss code status, despite prefacing the discussion with a "disclaimer" that we have to ask everyone this question and we don't expect that she will have a cardiac or respiratory arrest during this admission. The patient refused to stay for further treatment.
This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (had her 1st dose on 3/30/21 and never went back for the 2nd) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (had her 1st dose on 3/30/21 and never went back for the 2nd). At the time of the report, PRODUCT DOSE OMISSION ISSUE (had her 1st dose on 3/30/21 and never went back for the 2nd) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were provided. No treatment Medications were provided. Pharmacist wanted to know What happens when they wait more than 42 days to get their 2nd dose.
Vaso Vagal event:  Patient was very nervous prior to receiving vaccine.  Tolerated vaccination well, sat 10 minutes after receiving vaccine.  Mother was checking out and patient met mother at reception desk.  After 3 minutes or so patient fainted.  Hit back of head on exit door.  She was out for 10-15 seconds.  Patient came to, fundus was clear w/o PE.  Patient alert and responsive and appropriate when questioned.
This information on previous events was received on 10/15/01 upon receipt of order by MD to continue immunizations. Child was hospitalized 3 or 4 days, post vax, Mother said the child was in the hospital for 2 days and then transferred to another hospital for 2 days due to seizure activity and test resulting from seizures. She was started on Dilantin and Phenobarbital after 2/01 episode. She had another seizure after DTAP and Prevnar on 4/12/01. At this event, Phenobarbital and Dilantin had already been stopped. She has had other seizure activity at times other than post vax. Pt had vaccines on 10/18/01 upon receipt of approval from PMD. On 11/19/01 to date, the mother has not reported adverse event, if any, that was after injections given on 10/18/01.
Approx 5-10 mins post vax pt collapsed unconscious on floor; color was dusty, P48, unresponsive; MD dx vagal response, h/a;
Information has been received from a nurse concerning a 19 year old female with no pertinent medical history or drug reactions allergies who on 8/15/06 was vaccinated IM with the first dose of HPV rL1 6 11 16 18 VLP vaccine yeast (lot 653650/0702F). Concomitant therapy included Menactra. On an unspecified date the pt was given tuberculin purified protein derivative. On 8/15/06, 5 minutes after vaccination with HPV rL1 6 11 16 18 VLP vaccine yeast, the pt became faint. The pt was given water and chocolate as treatment. Subsequently, the pt recovered on 8/15/06. Additional information has been requested. 01/05/2007 Initial and follow-up information has been received from a nurse concerning a 19 year old female patient with no pertinent medical history or drug reactions/allergies who on 15-AUG-2006 at 9:00 AM was vaccinated intramuscularly with the first dose of GARDASIL (lot #653650/0702F). Concomitant therapy included "MENACTRA". On an unspecified date the patient was given tuberculin purified protein derivative. On 15-AUG-2006, within 10 minutes of receiving the vaccination, the patient became very faint and sweaty which lasted for approximately 60 seconds. The patient remained in the office for 45 minutes and was given water and chocolate as treatment. Subsequently, the patient recovered on 15-AUG-2006. No further information is expected.
12/27/21 pt brought to ED via ambulance; O2 sats 80% on RA, EMS placed pt on O2 supplementation; pt states he tested positive for COVID on 12/13/21; has had SOB, chest tightness, weakness x 1k; taking dexamethasone; ABX; pt tested positive for COVID on 12/27/21; O2 90% on 15L O2; pt eventually required intubation; ICU; poor O2 sats even on ventilator; condition worsened; bilateral COVID pneumonia. Pt passed away in the hospital.
Swollen lymph node in left armpit approx. 5 days after vaccination. Continues on 6th day (today). Achy and discomfort when moving arm or touching armpit.
SM received SPV, AVA #1, 10/20/08 & had mild headache same day. On 10/28/08 friends noticed red bumps on neck and chest. SM presented to PCM 10/29/08 for evaluation; at the time eruptions were confined to upper chest and appeared to be folliculitis; CBC & CMP were normal; he was afebrile and overall felt normal. SM had f/u with PMC 10/30/08 at which time eruptions were spread over entire torso-papular and pustular in nature, but otherwise asymptomatic. Derm photos were sent to the agency with diagnosis immune-mediated xanthem. At time of VAERS completion, skin eruptions remain.
This case meets vaccine breakthrough criteria .  PT ADMITTED FOR EVALUATION OF MELENA, CONFUSION, COUGH, BACK PAIN. PT PASSED AWAY 9/13/21
Pts mom states that on the morning of 9JAN92 pt had sz; pt had another sz on 16JAN92, 3 on 18JAN92 & a small one on 19JAN92; Pt seen by MD on 17JAN92 & started on Phenobarbital; Seen in ER 18JAN92;
The patient annotated "Parlayed left Vocal chord" Patient was seen at another clinic and is getting care. Patient did no give any specification on treatment nor where he was seen as a result of the reaction.
This spontaneous report as received from a dentist (who is also the mother of patient) refers to a male patient of unknown age. The patient's concurrent condition, medical history, drug reactions/allergies and concomitant medication were not reported. On an unknown date in 2013 the patient was vaccinated with first dose of GARDASIL and not GARDASIL 9 and second dose of GARDASIL was vaccinated one month later (dose, frequency, lot #, expiry date and indication were not reported) for prophylaxis. The patient's third dose of GARDASIL was missed. No adverse reactions reported. No product quality complaint was involved.
Patient told rph that she can faint when getting vaccination.  Pharmacist vaccinated and patient immediately began to feel dizzy and started shaking.  She did not pass out or fall out of her chair.  It was conveyed by the pharmacist to the technician staff that the patient was having difficulty breathing.  911 was called. 2nd pharmacist went into room to assess and pt was breathing fine.  She asked for some water and a bag of ice which were both given to patient. Paramedics arrived and took patient vitals.  Patient refused and further care and a relative came to pick her up.  Paramedics advised patient to follow up with further care if warranted.  When patient left she was feeling better.
Five days later I still have marked swelling and sharp pain when the injection site is touched. I became ill with flu-like symptoms that lasted three and a half days. I was exhausted and out of it. I feel better now, but my arm is still quite painful. I can't imagine wanting to take the second dose. I have no thought it was administered improperly, I just wonder if  the side effects are normal and worth the vaccination. I've never had an adverse reaction to any medication or vaccination previously.
ON TH EVENING OF 12/30, THE INJECTION SITE AND UPPER ARM WAS EXTREMELY ITCHY, RED AND SWOLLEN AND HAD A RAISED LUMP TO IT. I TOOK BENADRYL PO, AND THE SAME SYMPTOMS CONTINUED UNTIL 12/31-
Fussy. Fever to 102.8 started about 12 hours after vaccine and continued for about one day. CBC, Blood cultures obtained were within normal limits. CRP=2.9 (elevated)
Sudden appearance of redness around injection site 10 days after the injection.  Not itchy
Brand and lot of vaccine:  Moderna 047 A  2119 or it could be ou7 A 2119 Adverse events experienced and are they still occurring now:  both legs swelling l significant  more swollen 2 inches above ankle bones   What happened as a result of the adverse event? (doctor visit, ED or urgent care visit, hospitalization, life threatening illness, disability/permanent damage, death, none of these):  elevate feet any sob or worsening symptoms seek medical advise.
After checking injection site TDAP given in (L) deltoid per protocol. Upon completion of injection pt had no complaints. No redness or swelling noted at injection site at time of discharge.
I went to the Dr. and my BP was elevated and I was sent to get an EKG and they said they seen changes and said since I had COVID-19 they wanted to get an Echocardiogram the following week and they noticed mild thickening of the left sided Ventricle and increased my Amlodipine on 6/2/22 during my annual Pap Smear visit.
Pt vaccinated on day of discharge on 10/12/08 with influenza and pneumococcal vaccines. Pt was vaccinated with both vaccines on the Left arm as requested by pt as per RN. Pt then re-admitted to ED on 10/13/08 c/o fever,redness and swelling to Left upper arm. Pt treated with IV Zosyn and IV Vancomycin. 1/5/09-records received for DOS 10/13-10/17/08-DC DX: Left shoulder redness and swelling. Presented with 1 day C/O shoulder redness and swelling. Injection site reaction. Fever.
Vaccine given at 0837.  Pt arrived to observation site At 845 am and stated she felt faint. Stated that her lower lip was also starting to "feel swollen" and tingling.  Initial vitals: 147/79 69, 20, 99%  NP and MD evaluation:  PT noted sitting in chair, appears pale in color noted with periorbital and generalized facial edema. HEENT exam noted with oropharyngeal edema. Lungs CTA  Bendadryl 25 mg po given at 0851 by RN with no effect.  Facial redness and edema worsened.   Epi 3mg given at 8:55am, with improvement. After 5' facial redness and lower lip were worse, second epi pen given at 9:02.Vitals at 9:03 BP 162/87, HR 104, RR 20, 100% O2 on 4l O2. After the second dose of epi, facial redness and edema improved. She still had swelling and tingling of lower lip. EMS called at 9:09 and she was transported to hospital.
pt recv vax 10AM & immed onset of high pitched cont scream last 1 1/2hr, swelling & erythema, projectile vomiting x 20hr;fever 101.2 R;green diarrhea;entire leg massively swollen;
Tuesday evening: burning sensation on right midsection. Wednesday mid-day: tingling and then numb feeling on right midsection. Before bed, my right lower back was cramping with sharp, jabbing pain. Thursday morning: woke up in pain and rash on right midsection on abdomen and right lower back. I went to urgent care and diagnosed with SHINGLES and Prescribed ACYCLOVIR 800mg/1 pill/5x per day FOR 10 DAYS.
Pt recvd MMR on 14JAN92 was all right until evening of 15JAN92 w/sx of persistent vomiting x 10, diarrhea x 4 & listlessness; Taken to ER; WBC 18,000, >80% SEG, Na 132;
Itch; Red swelling welt about 4 inch diameter for about 4 days associated with soreness, Like a wasp sting.; Red swelling welt about 4 inch diameter for about 4 days associated with soreness, Like a wasp sting; Red swelling welt about 4 inch diameter for about 4 days associated with soreness, Like a wasp sting; Red swelling welt about 4 inch diameter for about 4 days associated with soreness, Like a wasp sting; This is a spontaneous report from a contactable other Health Care Professional (Patient, self-reported). A 62-year-old female patient (who was not pregnant at the time of vaccination), received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiry dates were not provided), via an unspecified route of administration, in Arm Right, on 05Feb2021, 03:45 AM, as a single dose for COVID-19 immunisation, at hospital. Medical history included low platelet count and had Known allergies to yellow jacket stings and sulfa drugs. Concomitant medications were not reported. Patient did not receive other vaccine in four weeks of vaccination. Patient did not receive Other medications in two weeks of vaccination. Patient was not diagnosed with COVID, prior vaccination. Patient has not been tested for COVID, post vaccination. It was reported that patient had Red swelling welt about 4 inch diameter for about 4 days associated with soreness, Like a wasp sting on 05Feb2021. Area remained red, but not elevated for 14 days. On day 10 (15Feb2021), it started to itch. No treatment was received for the events. Outcome of the events was recovered on an unknown date in Feb2021   Information about lot/ batch number has been requested.
12/27/22 presents to ED for "fatigue" "coronavirus concern". PMHx of "type 2 DM, CVA, HLD, HTN"
4/10/21 6pm side effects, feeling very tired, muscle pain & aches.  Continued until 4/11/21 12:05pm, pain was gone, did drink a lot of water.
Patient hospitalized due to COVID-19. Patient is fully vaccinated. Patient was in ICU.
Continuous headache a week. Fever-hot then cold week constantly for a week, Injection pain-stiff arm unable to use several days.  Extreme weakness up only to use BR. 3 weeks .Lymph nodes ached, but painful to touch weeks.  Confusion was the scariest side effect!
After receiving the three vaccines, pt. stated he was dizzy and lowered himself to the floor, body rigid with eyes rolling upwards.  This posture lasted approximately one minute.  Ammonia inhalant used after above episode and he stated to take it away.   Pt hit his head on the column of the connecting room.  Slight redness on back of head which disappeared within 5 minutes.  EMS called.  Paramedics arrived, took to truck for evaluation and transported Medical Center.
Started job Aug. 2012 = received Flu vaccine Oct 3, 2012. In Nov. 2012 to present, has exacerbation of asthma and upper respiratory sympt. Went to Dr. 12/21/12, diagnosed with URI. Relates illness to vaccination vs. Flu.
Soreness of injection site for 6 days, fever for 3 days, lymph node on left side swelled to size of golf ball,  cough, tiredness and scratchy throat for 2 weeks or so, migraine headache for 10 days or so and current persistent headache
This spontaneous report as received from a registered pharmacist refers to an approximately 52 year old female patient. In approximately August 2011, "two years ago", the patient was vaccinated with a dose of ZOSTAVAX (route and lot # not reported). The pharmacist reported that in approximately 2011, "two weeks later" vaccination, the patient experienced a mild case of shingles. At the time of the report, the patient's outcome was unknown. Additional information is not expected.
Pain immediately after injection, Pain and swelling for 2 days with redness at the site and sensitivity to touch. Taken Tylenol for pain and swelling but no affect. Pain and swelling has gotten worse the past 2 days, not better.
Very red rash up and down both legs on front, thigh to ankles with rash dried out then itches; Very red rash up and down both legs on front, thigh to ankles with rash dried out then itches; looks really red around ankles; This is a spontaneous report from a contactable consumer (patient). A 87-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: ER8727, and Expiration date: Unknown), via an unspecified route of administration, administered in left arm on 18Mar2021 15:45 (at the age of 87-year-old) as dose 2, single for COVID-19 immunization, at other facility. The patient medical history included high cholesterol, HBP (High Blood Pressure), congestive heart failure, and have swelling from congestive heart failure issues. The concomitant medications included lisinopril (LISINOPRIL), metoprolol (METOPROLOL), fluticasone (FLUTICASONE), and furosemide (FUROSEMID). The patient had no known allergies. The patient received no other vaccine in 4 weeks. The patient did not have COVID prior vaccination and was not tested for COVID post vaccination. Previously the patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: EN6203, and Expiration date: Unknown), via an unspecified route of administration, administered in left arm on 25Feb2021 12:30 PM (at the age of 86-year-old) as dose 1, single for COVID-19 immunization. On 30Mar2021 09:00, the patient experienced very red rash up and down both legs on front, thigh to ankles with rash dried out then itches, looks really red around ankles where she typically had swelling from congestive heart failure issues. No treatment was given for the events. The outcome of the events was not resolved.  No follow-up attempts are possible. No further information is expected.
Covid arm. Seven days post vaccine a large, hard, tender knot appeared on my right arm at the injection site. Approx 2-3 in in diameter. It has continued to grow in size through today, day one of its appearance.
Vertigo from positional changes; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0171), via an unspecified route of administration in the right arm on 24Apr2021 at 13:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patient reported that he was a smoker. The patient had no known allergies to medications, food or other products. The patient did not receive any medication within two weeks of the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER8734), via an unspecified route of administration in the right arm on an unspecified date as a single dose for COVID-19 immunisation. On 25Apr2021 at 09:00, the morning after the second dose, the patient experienced vertigo from positional changes. The patient reported that it had been 2 weeks since his second dose and the vertigo still remained but varied in how bad it was. The adverse event did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the event vertigo from positional changes which included treatment with meclizine. The clinical outcome of the event vertigo from positional changes was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
1 week post injection (minus 6 hours) itching , urticaria, half dollar circumference at injection site Prior to this, there was pain at injection site  post injection x 4 days
Immediate reaction of swelling, redness and heat at injection site.  Subsided within 45 minutes and patient went home.   The next day, she began to have tingling in her mouth and her tongue and throat began to swell.  She was rushed by ambulance to the ER   for treatment.
Patient's wife reported severe shaking and nausea, as well as vomiting and overall not feeling well. She said shaking started in the evening after receiving the vaccine at 4:30 that day.
sore arm; This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY PAIN (sore arm) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.   On 28-Jan-2021, the patient experienced AXILLARY PAIN (sore arm). At the time of the report, AXILLARY PAIN (sore arm) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.   This case was linked to MOD-2021-027492 (Patient Link).
Very tired; diarrhea; upset stomach; vomiting; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 06Jul2021 12:00 (Lot number: Ew0183) at the age of 50 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Hbp" (unspecified if ongoing); "degenerative disc disease" (unspecified if ongoing). Concomitant medication(s) included: WELLBUTRIN; CHLORTHALIDONE; TRAZODON; XANAX; TOPIRAMATE. Vaccination history included: Bnt162b2 (Product: COVID 19, Lot number: Ew0183, Lot unknown: False, Dose Number: 1), for Covid-19 immunisation. The following information was reported: FATIGUE (non-serious) with onset 07Jul2021, outcome "recovered with sequelae" (2021), described as "Very tired"; DIARRHOEA (non-serious) with onset 07Jul2021, outcome "recovered with sequelae" (2021), described as "diarrhea"; ABDOMINAL DISCOMFORT (non-serious) with onset 07Jul2021, outcome "recovered with sequelae" (2021), described as "upset stomach"; VOMITING (non-serious) with onset 07Jul2021, outcome "recovered with sequelae" (2021), described as "vomiting". Therapeutic measures were not taken as a result of fatigue, diarrhoea, abdominal discomfort, vomiting.  Additional Information: Facility type vaccine was reported as, Hospital. The patient had no known allergies. No vaccine taken four weeks after covid vaccination. The patient had no covid prior vaccination. The patient was not tested positive post vaccination.  Follow-up attempts are completed. No further information is expected.